Effects of Bifidobacterium breve on inflammatory gene expression in neonatal and weaning rat intestine

Pediatric Research

Volumn 71, Issue 1, 2012, Pages 46-53

  Ohtsuka, Yoshikazu ^a   Ikegami, Takako ^a   Izumi, Hirohisa ^b   Namura, Mariko ^b   Ikeda, Tomomi ^a   Ikuse, Tamaki ^a   Baba, Yosuke ^a   Kudo, Takahiro ^a   Suzuki, Ryuyo ^a   Shimizu, Toshiaki ^a  

^a JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MORINAGA MILK INDUSTRY CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIFIDOBACTERIUM BREVE EXTRACT; CD3 ANTIGEN; CD3D ANTIGEN; COMPLEMENTARY DNA; GLUTATHIONE PEROXIDASE 2; LIPOPOLYSACCHARIDE BINDING PROTEIN; LIPOPROTEIN LIPASE; MESSENGER RNA; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL COLONIZATION; BIFIDOBACTERIUM BREVE; CECUM; COLON; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION; IMMUNOMODULATION; INFANCY; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; SMALL INTESTINE; SPLEEN; WEANING;

ANIMALS; ANIMALS, NEWBORN; BIFIDOBACTERIUM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTESTINES; MICROARRAY ANALYSIS; RATS; WEANING;

EID: 83655211577     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2011.11     Document Type: Article

References (27)

1. Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria, 2001. (http://www.who.int/foodsafety/publications/fs- management/en/probiotics.pdf).
2. Yang YX, He M, Hu G, et al. Effect of a fermented milk containing Bifidobacterium lactis DN-173010 on Chinese constipated women. World J Gastroenterol 2008;14:6237-43.
3. Coccorullo P, Strisciuglio C, Martinelli M, Miele E, Greco L, Staiano A. Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation: a double-blind, randomized, placebo-controlled study. J Pediatr 2010;157:598-602.
4. Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebocontrolled trial. Lancet 2001;357:1076-9. (Pubitemid 32322538)
5. Xiao JZ, Kondo S, Yanagisawa N, et al. Probiotics in the treatment of Japanese cedar pollinosis: a double-blind placebo-controlled trial. Clin Exp Allergy 2006;36:1425-35. (Pubitemid 44674127)
6. Inoue Y, Iwabuchi N, Xiao JZ, Yaeshima T, Iwatsuki K. Suppressive effects of bifidobacterium breve strain M-16V on T-helper type 2 immune responses in a murine model. Biol Pharm Bull 2009;32:760-3.
7. Torii A, Torii S, Fujiwara S, Tanaka H, Inagaki N, Nagai H. Lactobacillus Acidophilus strain L-92 regulates the production of Th1 cytokine as well as Th2 cytokines. Allergol Int 2007;56:293-301. (Pubitemid 47442398)
8. Nonaka Y, Izumo T, Izumi F, et al. Antiallergic effects of Lactobacillus pentosus strain S-PT84 mediated by modulation of Th1/Th2 immunobalance and induction of IL-10 production. Int Arch Allergy Immunol 2008;145:249-57. (Pubitemid 351301317)
9. Schouten B, van Esch BC, Hofman GA, et al. Cow milk allergy symptoms are reduced in mice fed dietary synbiotics during oral sensitization with whey. J Nutr 2009;139:1398-403.
10. Hougee S, Vriesema AJ, Wijering SC, et al. Oral treatment with probiotics reduces allergic symptoms in ovalbumin-sensitized mice: a bacterial strain comparative study. Int Arch Allergy Immunol 2010;151: 107-17.
11. Li Y, Shimizu T, Hosaka A, Kaneko N, Ohtsuka Y, Yamashiro Y. Effects of Bifidobacterium breve supplementation on intestinal flora of low birth weight infants. Pediatr Int 2004;46:509-15. (Pubitemid 39423192)
12. Fujii T, Ohtsuka Y, Lee T, et al. Bifidobacterium breve enhances transforming growth factor beta1 signaling by regulating Smad7 expression in preterm infants. J Pediatr Gastroenterol Nutr 2006;43:83-8. (Pubitemid 44022391)
13. Abe F, Miyauchi H, Uchijima A, Yaeshima T, Iwatsuki K Stability of bifidobacteria in powdered formula. Int J Food Sci Tech 2009;44:718-24.
14. Odamaki T, Xiao JZ, Iwabuchi N, et al. Fluctuation of fecal microbiota in individuals with Japanese cedar pollinosis during the pollen season and influence of probiotic intake. J Investig Allergol Clin Immunol 2007;17:92-100. (Pubitemid 46623710)
15. Bartosch S, Fite A, Macfarlane GT, McMurdo ME. Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl Environ Microbiol 2004;70: 3575-81. (Pubitemid 38745906)
16. Matsuki T, Watanabe K, Fujimoto J, et al. Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria. Appl Environ Microbiol 2004;70:167-73. (Pubitemid 38090201)
17. Delroisse JM, Boulvin AL, Parmentier I, Dauphin RD, Vandenbol M, Portetelle D. Quantification of Bifidobacterium spp. and Lactobacillus spp. in rat fecal samples by real-time PCR. Microbiol Res 2008;163:663-70.
18. Karlsson A, Jägervall A, Pettersson M, Andersson AK, Gillberg PG, Melgar S. Dextran sulphate sodium induces acute colitis and alters hepatic function in hamsters. Int Immunopharmacol 2008;8:20-27. (Pubitemid 350214555)
19. Ritzka M, Stanke F, Jansen S, et al. The CLCA gene locus as a modulator of the gastrointestinal basic defect in cystic fibrosis. Hum Genet 2004;115:483-91. (Pubitemid 39562278)
20. Te Velde AA, Pronk I, de Kort F, Stokkers PC. Glutathione peroxidase 2 and aquaporin 8 as new markers for colonic inflammation in experimental colitis and inflammatory bowel diseases: an important role for H2O2? Eur J Gastroenterol Hepatol 2008;20:555-60. (Pubitemid 351667896)
21. Dincer Y, Erzin Y, Himmetoglu S, Gunes KN, Bal K, Akcay T. Oxidative DNA damage and antioxidant activity in patients with inflammatory bowel disease. Dig Dis Sci 2007;52:1636-41. (Pubitemid 46870559)
22. Kruidenier L, Kuiper I, Van Duijn W, et al. Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease. J Pathol 2003;201:17-27. (Pubitemid 37121199)
23. Van Overtvelt L, Moussu H, Horiot S, et al. Lactic acid bacteria as adjuvants for sublingual allergy vaccines. Vaccine 2010;28:2986-92.
24. Wall R, Ross RP, Shanahan F, et al. Metabolic activity of the enteric microbiota influences the fatty acid composition of murine and porcine liver and adipose tissues. Am J Clin Nutr 2009;89:1393-401.
25. Ruemmele FM, Bier D, Marteau P, et al. Clinical evidence for immunomodulatory effects of probiotic bacteria. J Pediatr Gastroenterol Nutr 2009;48:126-41.
26. Shima T, Fukushima K, Setoyama H, et al. Differential effects of two probiotic strains with different bacteriological properties on intestinal gene expression, with special reference to indigenous bacteria. FEMS Immunol Med Microbiol 2008;52:69-77.
27. Hoarau C, Lagaraine C, Martin L, Velge-Roussel F, Lebranchu Y. Supernatant of Bifidobacterium breve induces dendritic cell maturation, activation, and survival through a Toll-like receptor 2 pathway. J Allergy Clin Immunol 2006;117:696-702. (Pubitemid 43340238)